MedPath

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Completed
Conditions
Ankylosing Spondylitis
Registration Number
NCT01387802
Lead Sponsor
AbbVie (prior sponsor, Abbott)
Brief Summary

The current study will assess the real - life effectiveness of adalimumab in the management of Ankylosing Spondylitis (AS) with emphasis on the prevention and management of extra-articular manifestations.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
722
Inclusion Criteria
  • Adult >= 18 years old
  • Has provided written informed consent allowing the use of their data for the study and providing permission for contact by the study personnel
  • Active Ankylosing Spondylitis as per the judgment of the treating physician
  • Inadequate response or non tolerant to current NSAID (Nonsteroidal Anti-Inflammatory Drug) or DMARD (Disease-Modifying Anti Rheumatic Drug) based treatment for AS
Exclusion Criteria
  • Currently participating in another prospective study including controlled clinical trials and observational studies
  • Patient cannot or will not sign informed consent
  • Stable disease with adequate tolerance and response to current treatment and no change in treatment is indicated
  • Previous treatment with anti-TNF (Tumor Necrosis Factor) or other biologic agent
  • Presence of other condition that, in the opinion of the treating physician, prohibits the patient from participating in the study or obscures the assessment of the treatment of AS

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Occurrence, flare-up or exacerbation of Extra Articular Manifestations in PsoriasisEvery 3 months up to 6 months, then every 6 months up to 24 months

Baseline will be assessed as follows: Never Present, Positive History (Not present- Complete Remission,Time since remission onset; Present- Assessment of severity using a five point Likert scale (0 = Absent (Clear for Psoriasis); 5 = Most Severe)) Follow-up visits will be assessed as follows:Not present (Never present, Complete remission) Present (New Onset or Recurrence, Assessment of severity using a five point Likert scale (0 = Absent; 5 = Most Severe))

Occurrence, flare-up or exacerbation of Extra Articular Manifestations in UveitisEvery 3 months up to 6 months, then every 6 months up to 24 months

Baseline will be assessed as follows: Never Present, Positive History (Not present- Complete Remission,Time since remission onset; Present- Assessment of severity using a five point Likert scale (0 = Absent (Clear for Psoriasis); 5 = Most Severe)) Follow-up visits will be assessed as follows:Not present (Never present, Complete remission) Present (New Onset or Recurrence, Assessment of severity using a five point Likert scale (0 = Absent; 5 = Most Severe))

Occurrence, flare-up or exacerbation of Extra Articular Manifestations in Inflammatory Bowel DiseaseEvery 3 months up to 6 months, then every 6 months up to 24 months

Baseline will be assessed as follows: Never Present, Positive History (Not present- Complete Remission,Time since remission onset; Present- Assessment of severity using a five point Likert scale (0 = Absent (Clear for Psoriasis); 5 = Most Severe)) Follow-up visits will be assessed as follows:Not present (Never present, Complete remission) Present (New Onset or Recurrence, Assessment of severity using a five point Likert scale (0 = Absent; 5 = Most Severe))

Occurrence, flare-up or exacerbation of Extra Articular Manifestations in Enthesitis of the Heel: Achilles Tendon and Plantar FasciaEvery 3 months up to 6 months, then every 6 months up to 24 months

Baseline will be assessed as follows: Never Present, Positive History (Not present- Complete Remission,Time since remission onset; Present- Assessment of severity using a five point Likert scale (0 = Absent (Clear for Psoriasis); 5 = Most Severe)) Follow-up visits will be assessed as follows:Not present (Never present, Complete remission) Present (New Onset or Recurrence, Assessment of severity using a five point Likert scale (0 = Absent; 5 = Most Severe))

Secondary Outcome Measures
NameTimeMethod
PASQ (Psoriasis and Arthritis Screening Questionnaire)Every 3 months up to 6 months, then every 6 months up to 24 months

This is an 11 item tool that ascertains self reported presence of joint pain and swelling.

BASDAI (Bath AS Disease Activity Index)Every 3 months up to 6 months, then every 6 months up to 24 months

This is a 100 VAS with 0 indicating lowest disease activity and 10 highest disease activity

BASFI (Bath AS Functional Assay)Every 3 months up to 6 months, then every 6 months up to 24 months

This is a 100 VAS with 0 indicating lowest functional limitations and 10 highest functional limitations

Trial Locations

Locations (56)

Dr. Barbara T. Blumenauer Inc. /ID# 55226

๐Ÿ‡จ๐Ÿ‡ฆ

Kamloops, British Columbia, Canada

Ecker, Fredericton, CA /ID# 54748

๐Ÿ‡จ๐Ÿ‡ฆ

Fredericton, New Brunswick, Canada

Pont, Cranbrook, BC, CA /ID# 55242

๐Ÿ‡จ๐Ÿ‡ฆ

Cranbrook, British Columbia, Canada

Dr. Maqbool R. Sheriff Inc. /ID# 55247

๐Ÿ‡จ๐Ÿ‡ฆ

Nanaimo, British Columbia, Canada

Stewart, Penticton, CA /ID# 67096

๐Ÿ‡จ๐Ÿ‡ฆ

Penticton, British Columbia, Canada

Dr. Michael Buchanan, Inc. /ID# 55227

๐Ÿ‡จ๐Ÿ‡ฆ

Prince George, British Columbia, Canada

Dr. J. Antonio Avina-Zubieta /ID# 68263

๐Ÿ‡จ๐Ÿ‡ฆ

Richmond, British Columbia, Canada

Dr. Alfonso Verdejo Inc. /ID# 54572

๐Ÿ‡จ๐Ÿ‡ฆ

Vancouver, British Columbia, Canada

Dr. Milton F. Baker Inc. /ID# 55197

๐Ÿ‡จ๐Ÿ‡ฆ

Victoria, British Columbia, Canada

Bulleid Henderson Prof. Corp. /ID# 55256

๐Ÿ‡จ๐Ÿ‡ฆ

Fredericton, New Brunswick, Canada

Nexus Clinical Research /ID# 54757

๐Ÿ‡จ๐Ÿ‡ฆ

St. John's, Newfoundland and Labrador, Canada

St. Clare's Mercy Hospital /ID# 54767

๐Ÿ‡จ๐Ÿ‡ฆ

St. John's, Newfoundland and Labrador, Canada

Credit Valley Rheumatology /ID# 54750

๐Ÿ‡จ๐Ÿ‡ฆ

Mississauga, Ontario, Canada

Karasik, Toronto, CA /ID# 54751

๐Ÿ‡จ๐Ÿ‡ฆ

Toronto, Ontario, Canada

Jewish General Hospital /ID# 63655

๐Ÿ‡จ๐Ÿ‡ฆ

Montreal, Quebec, Canada

Rheumatology Clinic /ID# 54768

๐Ÿ‡จ๐Ÿ‡ฆ

Calgary, Alberta, Canada

Associate Clinic /ID# 64274

๐Ÿ‡จ๐Ÿ‡ฆ

Calgary, Alberta, Canada

Manitoba Clinic /ID# 54580

๐Ÿ‡จ๐Ÿ‡ฆ

Winnipeg, Manitoba, Canada

Qe Ii Hsc /Id# 55261

๐Ÿ‡จ๐Ÿ‡ฆ

Halifax, Nova Scotia, Canada

Dr. Juris Lazovskis Inc. /ID# 61562

๐Ÿ‡จ๐Ÿ‡ฆ

Sydney, Nova Scotia, Canada

Pavlova, Hamilton, CA /ID# 65011

๐Ÿ‡จ๐Ÿ‡ฆ

Ancaster, Ontario, Canada

Waterside Clinique /ID# 72174

๐Ÿ‡จ๐Ÿ‡ฆ

Barrie, Ontario, Canada

Brockville Medical Center /ID# 65502

๐Ÿ‡จ๐Ÿ‡ฆ

Brockville, Ontario, Canada

Dr. Sanjay Dixit Medicine Professional Corporation /ID# 67347

๐Ÿ‡จ๐Ÿ‡ฆ

Burlington, Ontario, Canada

Aviva Clinical Trial Group /ID# 54764

๐Ÿ‡จ๐Ÿ‡ฆ

Burlington, Ontario, Canada

Dr. Chrisotomor Kouroukis & Dr /ID# 137831

๐Ÿ‡จ๐Ÿ‡ฆ

Dundas, Ontario, Canada

Dr. William G. Bensen Centre /ID# 54762

๐Ÿ‡จ๐Ÿ‡ฆ

Hamilton, Ontario, Canada

KW Musculoskeletal Research /ID# 70093

๐Ÿ‡จ๐Ÿ‡ฆ

Kitchener, Ontario, Canada

Charlton Medical Centre /ID# 133072

๐Ÿ‡จ๐Ÿ‡ฆ

Hamilton, Ontario, Canada

Charlton Medical Centre /ID# 55417

๐Ÿ‡จ๐Ÿ‡ฆ

Hamilton, Ontario, Canada

West Mountain Medical Center /ID# 128877

๐Ÿ‡จ๐Ÿ‡ฆ

Hamilton, Ontario, Canada

Brandusa Florica Med Prof Corp /ID# 81877

๐Ÿ‡จ๐Ÿ‡ฆ

Mississauga, Ontario, Canada

Montgomery, Mississauga, CA /ID# 54581

๐Ÿ‡จ๐Ÿ‡ฆ

Mississauga, Ontario, Canada

Rajwinder S. Dhillon Medicine /ID# 138671

๐Ÿ‡จ๐Ÿ‡ฆ

Niagara Falls, Ontario, Canada

Imtiaz MS Khan Medicine Prof /ID# 55401

๐Ÿ‡จ๐Ÿ‡ฆ

Mississauga, Ontario, Canada

Morassut, Nepean, Canada /ID# 55410

๐Ÿ‡จ๐Ÿ‡ฆ

Nepean, Ontario, Canada

The Arthritis Program Res Grp /ID# 54755

๐Ÿ‡จ๐Ÿ‡ฆ

Newmarket, Ontario, Canada

Kapur, Ottawa, Canada /ID# 55397

๐Ÿ‡จ๐Ÿ‡ฆ

Ottawa, Ontario, Canada

Jonathan Stein Med Prof Corp /ID# 55451

๐Ÿ‡จ๐Ÿ‡ฆ

Toronto, Ontario, Canada

Davis, Ottawa, CA /ID# 55296

๐Ÿ‡จ๐Ÿ‡ฆ

Ottawa, Ontario, Canada

Hamilton, Toronto, CA /ID# 54575

๐Ÿ‡จ๐Ÿ‡ฆ

Toronto, Ontario, Canada

Setty, Owen Sound, CA /ID# 54583

๐Ÿ‡จ๐Ÿ‡ฆ

Owen Sound, Ontario, Canada

Niagara Peninsula Arthritis Ct /ID# 67282

๐Ÿ‡จ๐Ÿ‡ฆ

St. Catharines, Ontario, Canada

Dr. Samuel K Silverberg /ID# 55449

๐Ÿ‡จ๐Ÿ‡ฆ

Toronto, Ontario, Canada

Pedvis Med Prof Corp /ID# 55411

๐Ÿ‡จ๐Ÿ‡ฆ

Toronto, Ontario, Canada

Ctr de Med Sportive de Laval /ID# 54576

๐Ÿ‡จ๐Ÿ‡ฆ

Laval, Quebec, Canada

Institut de Rhum. de Montreal /ID# 54761

๐Ÿ‡จ๐Ÿ‡ฆ

Montreal, Quebec, Canada

PSS Medical Inc. /ID# 54754

๐Ÿ‡จ๐Ÿ‡ฆ

Montreal, Quebec, Canada

Couture, Outremont, CA /ID# 54574

๐Ÿ‡จ๐Ÿ‡ฆ

Outremont, Quebec, Canada

Clinique Medicale Langelier /ID# 55460

๐Ÿ‡จ๐Ÿ‡ฆ

Saint-leonard, Quebec, Canada

Ctr. de Rheum de l'est du QC /ID# 54765

๐Ÿ‡จ๐Ÿ‡ฆ

Rimouski, Quebec, Canada

Groupe de Recherche en Maladies Osseuses /ID# 45623

๐Ÿ‡จ๐Ÿ‡ฆ

Sainte-foy, Quebec, Canada

Rheum Disease Ctr of Montreal /ID# 143963

๐Ÿ‡จ๐Ÿ‡ฆ

Westmount, Quebec, Canada

Ctr. de Recherche Musculo-Sque /ID# 55469

๐Ÿ‡จ๐Ÿ‡ฆ

Trois-riviรจres, Quebec, Canada

Hudson, Kamloops, Canada /ID# 54577

๐Ÿ‡จ๐Ÿ‡ฆ

Kamloops, British Columbia, Canada

Joshi, Brampton, Canada /ID# 54758

๐Ÿ‡จ๐Ÿ‡ฆ

Brampton, Ontario, Canada

ยฉ Copyright 2025. All Rights Reserved by MedPath